Turquoise Health

Turquoise ingests publicly disclosed hospital and payer price-transparency files mandated by federal rules. The company normalizes these inconsistent machine-readable files into a uniform data model that customers query for rate comparisons, contract negotiations, and patient estimates. New regulatory proposals, such as the February 2026 Transparency in Coverage rule, could expand the scope and usability of the underlying data.

Turquoise operates as a software and data infrastructure company. It does not deliver clinical care or process claims. The platform provides analytics and workflow tools that sit between providers, payers, and patients — helping each party access the pricing intelligence generated by price-transparency regulations.

Turquoise counts 300-plus organizations as customers, including health systems, health plans, employers, and state governments. The company publicly cites UNC Health as a client and partnered with New York City to build the NYC Health Care Price Comparison Tool. Use cases range from managed-care contracting and compliance to patient-facing price estimates.

Turquoise has not publicly disclosed profitability. The company is venture-backed and actively hiring, which is typical of growth-stage enterprise software firms. It generates revenue through platform subscriptions tied to pricing, contracting, and compliance workflows.

Turquoise is a direct beneficiary of federal price-transparency mandates. The 2021 Hospital Price Transparency rule and subsequent insurer transparency rules generate the raw data the platform processes. Turquoise participates in the regulatory conversation — for example, commenting on the February 2026 proposed rule that aims to make price files more standardized and usable.